J&J, Bavarian Nordic and GSK involved in upcoming Ebola vax trials; Researchers develop rheumatoid arthritis immunotherapy;

> Upcoming Ebola vaccine trials in Ghana will be led by Johnson & Johnson ($JNJ) and Bavarian Nordic in Phase I and GlaxoSmithKline ($GSK) in Phase II. Report

> Australia's University of Queensland researchers developed an immunotherapy for people with the most common form of rheumatoid arthritis. More

> Cellular Biomedicine Group ($CBMG) acquired from Blackbird Bio Finance a cancer vaccine to be used in a trial of non-small cell lung cancer. Release

> A cancer vaccine from Australia's Regenus, originally tried in dogs, will be used in 21 humans with advanced cancers who have exhausted all available treatment regimens. Report

Suggested Articles

Amid the COVID-19 pandemic, many teams of researchers are working on potential vaccines. We asked experts to assess progress—and point out challenges.

Fujifilm says it is prepared to ramp up production of Avigan for any country that wants to try it as a potential treatment for COVID-19.

Pfizer posted positive top-line results for a trial of its 20-valent pneumococcal vaccine, potentially setting up a filing by the end of 2020.